Renee Hightower

Renee Hightower is an experienced professional in the ophthalmology sector, currently serving as Associate Director of Strategic Accounts in Ophthalmology at Apellis Pharmaceuticals since May 2022. Prior to this role, Renee held the position of Key Account Manager at Ocular Therapeutix, Inc. from 2019 to May 2022, where responsibilities included the launch of DEXTENZA in the Washington, DC area and training physicians and staff on its use. Previous experience includes serving as a Senior Clinical Specialist at Genentech from March 2006 to May 2019, successfully establishing LUCENTIS in the same region, and roles at Pfizer, Pharmacia Corporation, and Alcon, focusing on ophthalmology sales. Renee holds a B.S. in Business-Marketing from Hampton University and has a foundational education from Withrow University High School.